Changes in diameter of coronary narrowings and translesional hemodynamics after intracoronary nitroglycerin

The American Journal of Cardiology
B P KimballN Dafopoulos

Abstract

The effect of intracoronary nitroglycerin on coronary stenosis dimensions and translesional hemodynamics was evaluated in 38 subjects (74 stenoses) referred for diagnostic coronary arteriography. Quantitative coronary arteriography was performed with standard Newtonian fluid dynamic equations used to estimate transstenotic gradients. Since intracoronary nitroglycerin can induce significant myocardial hyperemia (increased flow velocity), with increased translesional pressure gradients and a decrease in distal intraluminal pressure, the potential effect on subendocardial flow distribution was also analyzed. Minimum stenotic diameter significantly increased postnitroglycerin (NTG) (preNTG 1.42 vs postNTG 1.82 mm, p less than 0.01), with a decrease in relative percent diameter stenosis (preNTG 45.7 vs postNTG 40.7%, p less than 0.05). When changes in minimum stenotic diameter were analyzed according to stenosis severity (quartiles), the greatest effect was noted in those lesions with the least severe stenosis (quartile no. 1, 0.49 vs quartile no. 4, 0.32 mm, p less than 0.05). If coronary blood flow velocity remains at baseline values (4 cm/s), intracoronary nitroglycerin was predicted to significantly decrease transstenotic pressu...Continue Reading

References

Jul 1, 1975·IEEE Transactions on Bio-medical Engineering·S E Logan
Feb 1, 1989·Journal of the American College of Cardiology·A E Moreyra, J B Kostis
Mar 25, 1988·The American Journal of Cardiology·K F Bachmann, R E Gansser
Nov 1, 1972·The Journal of Clinical Investigation·S F VatnerD Franklin
May 1, 1968·Circulation Research·W M Fam, M McGregor
May 1, 1980·British Heart Journal·W RafflenbeulT N James

❮ Previous
Next ❯

Citations

Nov 1, 1993·American Heart Journal·N A JaffraniJ Somberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.